Quince Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
03 Settembre 2024 - 10:05PM
Business Wire
Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage
biotechnology company dedicated to unlocking the power of a
patient’s own biology for the treatment of rare diseases, today
announced that Dirk Thye, M.D., Quince’s Chief Executive Officer
and Chief Medical Officer, will present at the H.C. Wainwright 26th
Annual Global Investment Conference on September 9, 2024 beginning
at 7 a.m. Eastern Time.
A webcast of the presentation will be accessible on the Events
page under the News & Events heading of Quince’s Investor
Relations website at ir.quincetx.com.
About Quince Therapeutics
Quince Therapeutics (Nasdaq: QNCX) is a late-stage biotechnology
company dedicated to unlocking the power of a patient’s own biology
for the treatment of rare diseases. For more information on the
company and its latest news, visit www.quincetx.com and follow
Quince Therapeutics on social media platforms LinkedIn, Facebook,
X, and YouTube.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240903061244/en/
Media & Investor Contact: Stacy Roughan Quince
Therapeutics, Inc. Vice President, Corporate Communications &
Investor Relations ir@quincetx.com
Grafico Azioni Quince Therapeutics (NASDAQ:QNCX)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni Quince Therapeutics (NASDAQ:QNCX)
Storico
Da Dic 2023 a Dic 2024
